We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+8.85%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$598M
AUM Growth
+$76.5M
Cap. Flow
+$64.6M
Cap. Flow %
10.8%
Top 10 Hldgs %
39.45%
Holding
336
New
90
Increased
41
Reduced
12
Closed
71

Sector Composition

Rank Sector Weight
1 Technology 19.7%
2 Healthcare 18.49%
3 Financials 10.5%
4 Industrials 9.85%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLRCW
251
DELISTED
ClimateRock Warrant
CLRCW
$1.13K ﹤0.01%
34,703
GLLIW
252
DELISTED
Globalink Investment Inc. Warrants
GLLIW
$1.06K ﹤0.01%
52,900
UTAAW
253
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$1.04K ﹤0.01%
+14,751
New +$1.81K
MSAIW icon
254
MultiSensor AI Holdings Warrant
MSAIW
$751K
$998 ﹤0.01%
24,900
DISTW
255
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$916 ﹤0.01%
31,050
ALSAW
256
DELISTED
Alpha Star Acquisition Corp Warrants
ALSAW
$911 ﹤0.01%
90,200
ROCLW
257
DELISTED
Roth CH Acquisition V Co. Warrant
ROCLW
$844 ﹤0.01%
+10,550
New +$722
ADERW
258
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$838 ﹤0.01%
12,700
OCAXW
259
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$762 ﹤0.01%
19,050
NRACW
260
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$630 ﹤0.01%
12,566
JWSM.WS
261
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$628 ﹤0.01%
12,567
FMIVW
262
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$12 ﹤0.01%
24,325
BIO icon
263
Bio-Rad Laboratories Class A
BIO
$9.53B
-500
Closed -$240K
CCI icon
264
Crown Castle
CCI
$31.3B
-1,500
Closed -$201K
HSPOU
265
DELISTED
Horizon Space Acquisition I Corp Unit
HSPOU
-67,700
Closed -$707K
ITGR icon
266
Integer Holdings
ITGR
$4.25B
-4,000
Closed -$310K
MSAI icon
267
MultiSensor AI
MSAI
$10.8M
-830
Closed -$345K
NPWR icon
268
NET Power
NPWR
$143M
-69,100
Closed -$707K
TMCI icon
269
Treace Medical Concepts
TMCI
$308M
-10,000
Closed -$252K
TYGO icon
270
Tigo Energy
TYGO
$96M
-88,979
Closed -$929K
VRTX icon
271
Vertex Pharmaceuticals
VRTX
$134B
-700
Closed -$221K
VYX icon
272
NCR Voyix
VYX
$1.11B
-36,920
Closed -$534K
GRML
273
Greenland Mines Ltd
GRML
$31.5M
-100,000
Closed -$1.03M
SVIIU
274
DELISTED
Spring Valley Acquisition Corp II Unit
SVIIU
-129,700
Closed -$1.38M
CLRC
275
DELISTED
ClimateRock Class A Ordinary Shares
CLRC
-69,406
Closed -$720K

Similar funds

Gabelli & Co Investment Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, Gabelli & Co Investment Advisers held 336 positions worth $598M, up 15% from $521M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Gabelli & Co Investment Advisers deployed $64.6M of net new capital in Q2 2023, opening 90 new positions and adding to 41 existing holdings. Its largest new stake was IVERIC bio, Inc. Common Stock: 684,950 shares worth $26.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rogers Corp, an estimated $11.3M trimmed.

  • Gabelli & Co Investment Advisers's largest Q2 2023 buy was IVERIC bio, Inc. Common Stock: 684,950 shares worth $26.9M.
  • Gabelli & Co Investment Advisers added most to National Instruments Corp in Q2 2023, an estimated $17.7M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2023 reduction was Rogers Corp, cutting an estimated $11.3M.
  • Gabelli & Co Investment Advisers fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $25.9M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 39% of its $598M portfolio in Q2 2023.
  • Gabelli & Co Investment Advisers opened 90 new positions and closed 71 in Q2 2023.
  • Gabelli & Co Investment Advisers's portfolio value rose 15% quarter-over-quarter to $598M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.